Related Experiment Video
Updated: Sep 5, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Immunoglobulin Gene Sequence as an Inherited and Acquired Risk Factor for Chronic Lymphocytic Leukemia
1Institute of Immunology, University Medical Center, 89081 Ulm, Germany.
Insights
Mutations in immunoglobulin genes, including specific light chain variants like IGLV3-21R110G, are linked to chronic lymphocytic leukemia (CLL) development. These mutations promote autonomous B-cell signaling, impacting CLL pathogenesis and prognosis.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Chronic lymphocytic leukemia (CLL) involves malignant B-cell accumulation.
- Autonomous B-cell signaling is crucial in CLL pathogenesis.
- Immunoglobulin gene mutations, particularly IGHV, serve as prognostic markers.
Purpose of the Study:
- To review current findings on immunoglobulin gene mutations in CLL.
- To explore the role of specific light chain mutations (e.g., IGLV3-21R110G) in CLL.
- To assess immunoglobulin gene sequence mutations as potential CLL risk factors.
Main Methods:
- Literature review of recent studies on CLL pathogenesis.
- Analysis of immunoglobulin gene sequence mutations and their impact.
- Correlation of mutations with B-cell signaling and disease prognosis.
Main Results:
- Specific light chain mutations like IGLV3-21R110G promote homotypic BCR-BCR interactions.
- This interaction leads to autonomous B-cell signaling, contributing to CLL.
- Mutated CLL (M-CLL) generally exhibits a more indolent course than unmutated CLL (U-CLL).
Conclusions:
- Immunoglobulin gene mutations are implicated in CLL development and progression.
- The IGLV3-21R110G mutation is a significant factor in CLL pathogenesis.
- Further research into immunoglobulin mutations may reveal novel therapeutic targets for CLL.
Abstract:
Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disease characterized by the accumulation of CD5+ CD19+ malignant B cells. Autonomous ligand-independent B-cell signaling is a key process involved in the development of CLL pathogenesis. Together with other cytogenetic alterations, mutations in the immunoglobulin heavy chain variable (IGHV) gene act as a prognostic marker for CLL, with mutated CLL (M-CLL) being far more indolent than unmutated CLL (U-CLL). Recent studies highlight the role of a specific light chain mutation, namely, IGLV3-21R110G, in the development and prognosis of CLL. Such a mutation increases the propensity of homotypic BCR-BCR interaction, leading to cell autonomous signaling. In this article, we review the current findings on immunoglobulin gene sequence mutations as a potential risk factor for developing CLL.
More Related Videos
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Non-LTR Retrotransposons
Cancer Prevention
Some...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...